Mode
Text Size
Log in / Sign up
N/A N=24 Randomized Single-blind Supportive Care

Factors Responsible for the Effectiveness of the Lund De-airing Technique

Complication of Surgical Procedure

Enrolled (actual)
24
Serious AEs
5.0%
Results posted
Dec 2013
Primary outcome: Primary: Quantitative Assessment of Air Embolism to the Brain After Completion of Open Left Heart Surgery — 49; 46 Air microemboli

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Open pleurae & conventional filling of heart (Procedure); Intact pleurae & staged filling of heart (Procedure)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Lund University
Primary completion
Dec 2013

Outcome Measures

OutcomeResultp-value
PRIMARY
Quantitative Assessment of Air Embolism to the Brain After Completion of Open Left Heart Surgery
65; 9 <0.01 sig
PRIMARY
Quantitative Assessment of Air Embolism to the Brain After Completion of Open Left Heart Surgery
65; 9 <0.01 sig
PRIMARY
Quantitative Assessment of Air Embolism to the Brain After Completion of Open Left Heart Surgery
65; 9 <0.01 sig
PRIMARY
Participants With <=Grade I Air Emboli as Assessed by Trans-esophageal Echocardiography (TEE) After Finished De-airing.
9; 10
PRIMARY
Participants With <=Grade I Air Emboli as Assessed by Trans-esophageal Echocardiography (TEE) After Finished De-airing.
9; 10
PRIMARY
Participants With <=Grade I Air Emboli as Assessed by Trans-esophageal Echocardiography (TEE) After Finished De-airing.
9; 10
PRIMARY
Duration of the De-airing Procedure
14; 8.5

Summary

The Lund de-airing technique is employed for cardiac de-airing in open left heart surgery. It consists of two main elements namely, opening of both pleura after the patient is on CPB (cardiopulmonary bypass)and disconnection of the ventilator before opening the left heart to ensure bilateral pulmonary collapse and a staged filling of the heart at termination of the CPB. The aim of this study is to analyze in a randomized manner two groups of patients to establish if one or both components are of primary importance for the effectiveness of the de-airing technique.

Eligibility Criteria

Inclusion Criteria

  • Patients planned for aortic valve replacement with or without coronary vein bypass grafts

Exclusion Criteria

  • Significant chronic obstructive pulmonary disease and emphysema
  • Previous history of thoracic or cardiac surgery
  • Patients requiring internal mammary artery harvesting
  • Unilateral or bilateral pulmonary adhesions to chest wall
  • Previous radiation to the chest

Intraoperative Exclusion Criteria:

  • Inability to obtain adequate bilateral Trans-cranial Echo-doppler signals
  • Adherent pleurae
  • Accidental opening of the pleurae
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01757704). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search